FDA issues emergency authorization for BD, BioGX's COVID-19 test
April 3, 2020 -- The U.S. Food and Drug Administration (FDA) has granted an emergency use authorization to Becton Dickinson (BD) and BioGX for their novel coronavirus test.
April 3, 2020 -- The U.S. Food and Drug Administration (FDA) has granted an emergency use authorization to Becton Dickinson (BD) and BioGX for their novel coronavirus test.
Ipsum gets FDA nod for COVID-19 test
April 3, 2020 -- Ipsum Diagnostics has received emergency use authorization from the U.S. Food and Drug Administration (FDA) for its IDx diagnostic test to identify individuals with SARS-CoV-2, the virus that causes the respiratory disease COVID-19.
April 3, 2020 -- Ipsum Diagnostics has received emergency use authorization from the U.S. Food and Drug Administration (FDA) for its IDx diagnostic test to identify individuals with SARS-CoV-2, the virus that causes the respiratory disease COVID-19.
MicroGenDX offers 24-hour coronavirus test of saliva and sputum samples
April 3, 2020 -- MicroGenDX is offering a real-time reverse transcription polymerase chain reaction test to detect the novel coronavirus in saliva and sputum samples.
April 3, 2020 -- MicroGenDX is offering a real-time reverse transcription polymerase chain reaction test to detect the novel coronavirus in saliva and sputum samples.
Siemens debuts test kit for COVID-19
April 3, 2020 -- Siemens Healthineers has created a fast-track diagnostics test kit to help identify patients with COVID-19.
April 3, 2020 -- Siemens Healthineers has created a fast-track diagnostics test kit to help identify patients with COVID-19.
Quest ramps up coronavirus testing amid reports of backlog
April 2, 2020 -- Quest Diagnostics said it is ramping up its coronavirus testing capability to 30,000 tests per day, while stressing that cases will need to be prioritized in light of very high demand. The announcement came amid news media reports claiming that the company is partly to blame for a big backlog of tests reported in California.
Discuss
April 2, 2020 -- Quest Diagnostics said it is ramping up its coronavirus testing capability to 30,000 tests per day, while stressing that cases will need to be prioritized in light of very high demand. The announcement came amid news media reports claiming that the company is partly to blame for a big backlog of tests reported in California.
Discuss Testing confirms bathhouse transmission of SARS-CoV-2
April 2, 2020 -- The transmission of SARS-CoV-2 among nine patients who used a bathhouse more than 400 miles north of Wuhan, China, has been confirmed via molecular testing and computed tomography scans, according to a research letter published March 30 in JAMA Network Open.
Discuss
April 2, 2020 -- The transmission of SARS-CoV-2 among nine patients who used a bathhouse more than 400 miles north of Wuhan, China, has been confirmed via molecular testing and computed tomography scans, according to a research letter published March 30 in JAMA Network Open.
Discuss Gene biomarker shows promise as alternative early Alzheimer's blood test
April 1, 2020 -- A gene called phosphoglycerate dehydrogenase (PHGDH) looks promising as a biomarker for early Alzheimer's disease based on a study of RNA blood tests published in the journal Current Biology. The results have potential to open a new avenue of research in blood testing for the disease, beyond beta amyloid and tau, researchers reported.
Discuss
April 1, 2020 -- A gene called phosphoglycerate dehydrogenase (PHGDH) looks promising as a biomarker for early Alzheimer's disease based on a study of RNA blood tests published in the journal Current Biology. The results have potential to open a new avenue of research in blood testing for the disease, beyond beta amyloid and tau, researchers reported.
Discuss FDA provides reference sequence data for SARS-CoV-2
April 1, 2020 -- The U.S. Food and Drug Administration (FDA) has collaborated with four expert entities to develop quality-controlled sequence data for the SARS-CoV-2 reference strain.
April 1, 2020 -- The U.S. Food and Drug Administration (FDA) has collaborated with four expert entities to develop quality-controlled sequence data for the SARS-CoV-2 reference strain.
BioIQ readies COVID-19 saliva test
April 1, 2020 -- Healthcare engagement and technology platform firm BioIQ announced that its saliva-based COVID-19 test will be available as soon as next week.
April 1, 2020 -- Healthcare engagement and technology platform firm BioIQ announced that its saliva-based COVID-19 test will be available as soon as next week.
NeuMoDx coronavirus test gets emergency authorization
April 1, 2020 -- NeuMoDx Molecular's assay for SARS-CoV-2 has received an emergency use authorization from the U.S. Food and Drug Administration.
April 1, 2020 -- NeuMoDx Molecular's assay for SARS-CoV-2 has received an emergency use authorization from the U.S. Food and Drug Administration.